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Abstract
The human prostacyclin receptor (hIP receptor) is a seven-transmembrane G protein-coupled receptor (GPCR) that plays a
critical role in vascular smooth muscle relaxation and platelet aggregation. hIP receptor dysfunction has been implicated in
numerous cardiovascular abnormalities, including myocardial infarction, hypertension, thrombosis and atherosclerosis.
Genomic sequencing has discovered several genetic variations in the PTGIR gene coding for hIP receptor, however, its
structure-function relationship has not been sufficiently explored. Here we set out to investigate the applicability of high
throughput random mutagenesis to study the structure-function relationship of hIP receptor. While chemical mutagenesis
was not suitable to generate a mutagenesis library with sufficient coverage, our data demonstrate error-prone PCR (epPCR)
mediated mutagenesis as a valuable method for the unbiased screening of residues regulating hIP receptor function and
expression. Here we describe the generation and functional characterization of an epPCR derived mutagenesis library
compromising.4000 mutants of the hIP receptor. We introduce next generation sequencing as a useful tool to validate the
quality of mutagenesis libraries by providing information about the coverage, mutation rate and mutational bias. We
identified 18 mutants of the hIP receptor that were expressed at the cell surface, but demonstrated impaired receptor
function. A total of 38 non-synonymous mutations were identified within the coding region of the hIP receptor, mapping to
36 distinct residues, including several mutations previously reported to affect the signaling of the hIP receptor. Thus, our
data demonstrates epPCR mediated random mutagenesis as a valuable and practical method to study the structure-
function relationship of GPCRs.
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Introduction
The human prostacyclin (PGI2) receptor (hIP receptor, Inter-
national Union Pharmacology nomenclature) is a seven trans-
membrane (TM) G protein-coupled receptor (GPCR) [1]. The
386 amino acid protein is encoded by the human prostacyclin
receptor gene (PTGIR) and is composed of a short N-terminal tail,
seven TM-spanning alpha-helical domains, three intra- and three
extracellular loops and a long c-terminal tail including two
palmitoylation sites. The receptor is further stabilized by two
disulfide bonds [2,3]. The hIP receptor is activated by binding of
prostacyclin which leads to the activation of membrane-bound
adenylyl cyclase, subsequent formation of the second messenger
cyclic adenosine monophosphate (cAMP) and activation of various
cellular responses [1]. The hIP receptor is ubiquitously expressed
in the body, but shows predominant expression in the cardiovas-
cular system, especially on platelets and vascular smooth muscle
cells where it plays a key role in vascular smooth muscle relaxation
and inhibition of platelet aggregation. Recent studies have
revealed a cardioprotective role of the IP receptor and hIP
receptor dysfunction has been implicated in numerous cardiovas-
cular abnormalities, including myocardial infarction, hyperten-
sion, thrombosis and atherosclerosis [4–9]. Furthermore, genetic
variants in the hIP receptor resulting in deficits of hIP receptor
function have been correlated with increased disease severity in
patients with coronary artery disease [10,11]. Thus, it is of
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paramount significance to understand the mechanisms and
structural requirements underlying hIP receptor function. Despite
significant progress in our understanding of GPCRs in general and
multiple studies using site-directed mutagenesis to identify residues
critical for agonist binding and hIP receptor activity [9], the details
of hIP receptor structure-function remain largely unknown.
Here we set out to explore the relationship between hIP
receptor structure and function using an unbiased, high-through-
put, random mutagenesis approach. We compared the applica-
bility of chemical mutagenesis and error-prone PCR mediated
mutagenesis to create a library covering the complete coding
region of the hIP receptor and analyzed the quality of our library
by next generation sequencing (NGS). Furthermore, we report the
functional characterization of .4000 hIP receptor mutants and
the identification of 18 mutants of the hIP receptor that
maintained expression but demonstrated a full or partial reduction
in receptor activity. Our results highlight the advantages of
random high throughput mutagenesis to gain insights in the
structure-function requirements of hIP receptor, as compared to
biased approaches using site-directed mutagenesis.
Experimental Procedures
Hydroxyl amine mutagenesis
Hydroxylamine mutagenesis, which reacts with pyrimidine
nucleotides to generate cytosine to thymidine transitions, was
adapted from a previous published protocol [12]. 5 ug HA-tagged
hPTGIR in pcDNA5 was incubated with 250 ml 1 M hydroxyl-
amine hydrochloride (Sigma Aldrich), pH 7 at 70uC for 32 to
128 min. Mutagenised plasmids were then isolated and washed at
least 3 times using the QiaQuick PCR purification kit (Qiagen),
and finally eluted with 50 mL EB buffer from the kit and diluted
with 50 mL sterile water. 1 mL of purified mutated plasmid was
transformed into 100 mL Invitrogen Library Efficiency DH5a
competent E. coli (Invitrogen). Transformed cells were then plated
onto Luria Broth (LB)-agar media supplemented with ampicillin
and grown O/N at 37uC. Individual bacterial colonies were
picked and grown O/N at 37uC, DNA was isolated, the hPTGIR
insert sequenced and the mutation rate per mutant determined
(Table 1).
Error-prone PCR mediated mutagenesis
Error-prone PCR (epPCR) mediated mutagenesis was per-
formed using the GeneMorph II Random Mutagenesis kit
(Stratagene). Briefly, 500–1000 ng of plasmid DNA (pcDNA5-
HA-hPTGIR) was mutagenized by PCR according to the
manufacturer’s protocol using the following primers: IPR-for: 59-
CGACTCACTATAGGGAGACCCAAGCTGG -39, IPR-rev:
59- CAACTAGAAGGCACAGTCGAGGCTGATC -39. PCR
products were separated by gel electrophoresis and purified using
a gel-extraction kit (Qiagen). After restriction enzyme digest
(HindIII and XhoI), the DNA was purified with a PCR
purification kit (Qiagen) and cloned into the parental vector
(pcDNA5-HA). Mutagenized DNA was transformed into E.coli
DH5aMax Efficiency (Invitrogen). For initial studies to determine
the mutation rate, between 100–200 single colonies were
handpicked. For the large mutant library prep around 4000
individual colonies were picked with a Mega-Pix robot (Genetix).
In both cases, colonies were transferred to 96-deep well blocks
containing 1.2 mL of terrific broth (TB)/Carbenicillin/Tylosin,
and grown at 37uC O/N in the HiGro incubator (Gene Machines,
Inc.). The next day glycerol stocks were made of the whole library
by transferring 100 ml of the bacterial culture into 70 mL of
50% glycerol/50% TB solution. The glycerol stocks were stored at
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280uC for future amplification of the library. DNA purification of
mutant clones from the remaining 96-deep well bacterial cultures
was performed by a RoboSeq 4204 prep robot (MWG Biotech)
with the NucleoSpin Robot-96 Plasmid Miniprep kit (Macherey-
Nagel). Purified plasmids in 96-well microtiter plates were
quantified with a PowerWave XS spectrometer (Bio-Tek) and
normalized to a final concentration of 40 ng/mL with a TheOnyx
(MWG Biotech) liquid-handling robot. The 96-well plates
containing normalized mutant DNA were compressed into 384-
deep well barcoded bioassay plates (Greiner Bio-One) by
transferring 62.5 mL of mutant plasmid with a MiniTrak robot
(Perkin Elmer) into assigned 384-well plate coordinates. In total,
twelve unique 384-well plates (approx. 4,000 mutants) containing
an individual clone within each well were generated. All plates
were stored at 220uC.
Next generation sequencing
All library constructs were pooled and the genomic library was
prepared and sequenced by Axeq Technologies on an Illumina
HiSeq 2000. The 101 bp paired-end reads were aligned to the
wild-type-sequence of human PTGIR using BWA (v0.7.4) with the
parameters -n 2 -t 12 (pmid 19451168). Alignments were
converted to bam (pmid: 19505943) and only high quality
nucleotides were counted at each position using the bamutils
basecalls function (pmid 23314324; bamutils basecall -ref wild-
type.fa -qual 40 epPCR.bam). Mutations were called against the
reference sequence and mutation rates calculated with R and the
plyr package (R Development Core Team (2008). R: A language
and environment for statistical computing. R Foundation for
Statistical Computing, Vienna, Austria. ISBN 3-900051-07-0,
URL http://www.R-project.org; [13]). Non-biased assessment of
codon usage was calculated by dividing the total mutations across
the coding sequence by the potential mutations. All potential
codons were then determined based on the three alterative bases at
each location, assuming one mutation per codon. The data has
been deposited in the NIH SRA database (BioProject:
PRJNA242280).
Cell culture and transfection
HEK293 GloSensor-20F cAMP cells (Promega) were main-
tained in DMEM supplemented with foetal bovine serum (10% v/
v) and hygromycin (200 mg/mL) at 37uC, 5% CO2. For
experiments, cells were harvested using trypsin/EDTA buffer
and seeded on to multiwell plates in CO2-independent medium
containing foetal bovine serum (10% v/v). Reverse-transfection of
cells with the mutant library was performed in 384-well black,
clear bottom plates using FuGENE6 (Promega) according to
manufacturer’s instructions. Briefly, 1 mL of cDNA library or wild-
type hIP receptor (40–100 ng) was seeded into the 384-well assay
plate using the Mosquito nanoliter dispenser. FuGENE6 was
diluted in OptiMEM to give a 1:3 DNA:FuGENE ratio (for 40 ng
cDNA, 0.12 ml FuGENE6 per well in 4 ml OptiMEM/384 well).
4 ml OptiMEM/FuGENE mixture was then added to cDNA in
384 well plate, and incubated at room temperature for 30 minutes,
with gentle shaking. 15 ml of cells (0.676106 cells/mL; 10,000
cells/well) was then added to the DNA/OptiMEM/FuGENE
mixture. Cells were then incubated overnight at 37uC, 5% CO2.
GloSensor cAMP assay
Kinetic analysis of cAMP accumulation in cells expressing hIP
receptor was conducted using transiently transfected cells. 10 mL
of 12% GloSensor reagent (4% [final]) in CO2-independent
medium containing FBS (10% v/v) was added to the cells and the
plate was incubated for 2 hour in the dark at room temperature.
Luminescence (analogue mode, sensitivity 2) was then read on the
FDSS7000 every 1.5 sec (integration time of 1.2 sec), for a total of
1000 samples. 5 mL of 7x MRE-269 [4-[(5,6-Diphenylpyrazin-2-
yl)(isopropyl)amino]butoxy] acetic acid (synthesized in house) was
transferred to the 384-well cell plate using the FDSS7000, after the
first 5 samples. Hits were characterized as mutants that resulted in
,25% of the response to MRE-269 in cells transfected with the
wild-type hIP receptor.
Receptor expression
The above assay was then repeated with expression analysis.
After transfection of selected mutant hIP and wild type receptors,
cells were incubated in CO2-independent medium containing FBS
(10% v/v); GloSensor reagent (4% v/v); Hoechst (1 mM); Alexa
FlourH -647 conjugated anti-HA antibody (1:500). Receptor
expression was analyzed after 30 min on the InCell2000. Nuclei
were visualized using DAPI settings (0.05 s exp), HA-tagged
receptor using Cy5 settings (1.5 sec exp) and cells were visualized
using bright field settings (0.05 s exp). The expression of mutant
receptor was analyzed using InCell Developer Toolbox 1.9.1
software. Cells were detected using Object Segmentation (kernel
size = 57, Sensitivity = 55), followed by Fill Holes and Sieve
(Binary) based on size (.10 mm2). Mean and Sum of the
fluorescence detected was taken for each well as an estimate of
the relative expression levels for each mutant receptor. Cells were
then incubated further at room temperature (2 hour in total) and
activity assessed as above.
Results and Discussion
Chemical mutagenesis
Mutations in the hIP receptor and impaired receptor function
have been correlated with cardiovascular disease [10,11], however
little is known about the structure-function relationship of the
receptor. The hIP receptor has been intensively studied by site-
directed mutagenesis, leading to the identification of critical
residues for receptor activation and ligand binding [9,11,14–17].
However, because of the labor-intensive nature of this approach,
these studies were focused on a limited number of residues that
were selected based on homology with other receptors or
molecular modeling approaches and are therefore highly biased.
In order to identify residues important for hIP receptor function
we set out to generate an unbiased library of hIP receptor mutants,
covering the complete coding region of the receptor, for
subsequent functional characterization.
In contrast to site-directed mutagenesis, random mutagenesis
does not require the a priori selection of particular residues but
rather allows for the generation and testing of thousands of amino
acid substitutions in an unbiased way. However, depending on the
mutagenesis method used, different degrees of bias regarding the
type of substitution made can be achieved.
Chemical mutagenesis is the most convenient method to
mutagenize a plasmid, since it does not involve any recombinant
manipulation or sub-cloning of the parental DNA, i.e. generally
the parental plasmid is incubated directly with one of several
chemicals and can be used directly for transformation after a
simple purification step [18–21]. Chemical mutagenesis can be
especially useful if low mutation rates are required or sub-cloning
of the targeted region is not possible. An obvious disadvantage is
the lack of specificity for a specific region and the limitation of
possible base pair changes, resulting in a highly biased library.
We set out to test the applicability of chemical mutagenesis to
generate a mutant library for the hIP receptor to gain additional,
unbiased insights into the relationship between the structure and
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function of this receptor. For this, we incubated the parental
plasmid coding for the hIP receptor with 1 M hydroxyl amine for
32 min–128 min. Treatment of double stranded DNA with
Hydroxyl amine is known to result in C-.T and G-.A transitions
thus allowing for only a limited fraction of possible substitutions
[21]. After a purification step, the DNA was transformed in E.coli.
As shown in Table 1 the number of resulting colonies was inversely
correlated to the time used for incubation with hydroxyl amine.
Longer incubation times are expected to result in higher mutation
rates, increasing the probability of mutations in regions of the
vector coding for the ampicillin resistance used for selection,
resulting in a loss of resistance. To determine the mutation rate in
the coding region of the hIP receptor, a representative number of
colonies were subsequently analyzed by Sanger sequencing. The
observed rate of mutations in the coding region of the hIP receptor
was very low, with an observed maximum of approximately one
mutation every 2.6 kb (Table 1). Notably, the number of colonies
obtained under these conditions would not suffice to generate a
mutagenesis library of sufficient size to cover the coding region of
hIP receptor. These results demonstrate the suitability of hydroxyl
amine mediated mutagenesis for the generation of libraries with
low mutations rates. For the purpose of our study, however, the
observed mutation rate was not sufficient.
Error-prone PCR mediated mutagenesis
Next we explored the feasibility of epPCR mediated mutagen-
esis to generate a mutant library for the hIP receptor. epPCR is
fast and facile, and the most commonly used method to create
random mutagenized libraries [22]. It is used to introduce random
mutations during PCR by compromising the fidelity of DNA
polymerase, resulting in the incorporation of incorrect nucleotides
during the PCR reaction and yielding randomly mutated products
[23]. The fidelity of the DNA polymerase and therefore the error
rate can be reduced by altering the reaction conditions for the
PCR, i.e. ion concentrations, amount of starting material, number
of cycles, or by using special variants of DNA polymerases with
known deficits in 39-59 exonuclease activity [22,24–26]. After the
epPCR, the library of mutated DNA sequences is cloned in a
suitable plasmid, making an additional purification and ligation
step necessary, but on the other hand ensuring that no mutations
are present outside the region of interest in the expression plasmid
used. A disadvantage of epPCR mutagenesis lies in the mutational
preference of the low-fidelity DNA polymerases used to introduce
the mutations, favoring substitution of certain nucleotides over
others resulting in a biased library [27,28]. One approach to
reduce the bias of the library and to increase diversity is to
combine two DNA polymerases with opposite mutational spectra
[29]. This approach has been proven to significantly reduce the
bias in the library and is used by multiple commercially available
mutagenesis kits. We used the commercially available Genemorph
II kit which uses a mixture of two polymerases, Taq and
Mutazymell, with opposite mutational spectra to reduce mutation
bias.
The estimated mutation frequency can be described as a
product of the DNA polymerase error rate and the number of
amplifications [30]. The more often a target is replicated, the more
errors are accumulated. Therefore the initial DNA amount can be
used to adjust the mutation frequency. We performed three
independent epPCR reactions with varying template DNA
concentrations, sub-cloned the PCR fragments in a plasmid
including an HA-tag and analyzed the mutation rates by
sequencing a small subset of the resulting colonies after
transformation in E.coli. As expected, the highest input of starting
material (1 ug) resulted in a low mutation rate of approximately
0.5 mutations per kb, the lower DNA input of 750 ng and 500 ng
yielded significantly higher mutation rates of approximately 0.8
and 1.5 mutations/kb, respectively (Table 2, Figure 1 A, B).
Simulation of optimal mutation rate
Low mutation rates lead to libraries with many functional
sequences (i.e. wild-type sequences and mutants with only a single
amino acid change), but small numbers of total mutations and
therefore overall low coverage (i.e. frequency with which a
particular amino acid has been mutated in the library). High
mutation rates enrich libraries for sequences with high numbers of
mutations therefore leading to less functional sequences and a
good coverage. However, the accumulation of mutations leads to a
decrease in the unique mutation rate (i.e. how often a particular
amino acid has been changed without any other mutations
occurring in the same plasmid) [31]. Thus, one has to find the
optimal mutation rate that balances overall mutation rate
(coverage), functional retention and uniqueness. Low mutation
rates with maximal unique mutation rate are optimal, but require
a larger number of mutants (library size) to guarantee sufficient
coverage. The distribution of the number of mutations per
construct is expected to be a binomial distribution, and for the ease
of downstream analysis of the ensemble of mutants we aimed to
maximize the number of single amino acid mutations and
minimize multiple and null mutations (i.e. the mode of the
distribution would be at 1). The penetrance of DNA mutations
into amino acid mutations is incomplete, and by simple in silico
simulation for all positions in a representative set of genes, we
determined the penetrance correction coefficient to be 0.75 (for
the target genes in the study, the coefficient was between 0.72 and
0.77). We have prepared a simple worksheet that allowed us to
simulate the expected number and distribution of amino acids in
our library as a function of the mutation rate (see Table S1). Using
this algorithm, we simulated the expected number and distribution
of amino acids in our library as a function of the mutation rate and
compared it to the distribution obtained by sequencing a small
number of mutated colonies (Figure 1C, D). As can be seen in
Table 3, a mutation rate of 1.1 mutations/kb is expected to
produce the most single amino acid changes, but at the same time
retaining 35% wild-type (non-mutated or silence nucleotide
mutations) sequences. The lowest fraction of wild-type sequences
in combination with high fractions of single and dual amino acid
changes can be obtained with a mutation rate of 1.5 mutations/kb.
Figure 1. Error-prone PCR mediated mutagenesis of hIP receptor. (A, B) Number and distribution of mutations per clone after error-prone
PCR mediated mutagenesis of hIP receptor using 750 ng (A) or 500 ng (B) parental PTGIR plasmid as input. Grey bars represent the expected
mutational spectrum at a mutation rate of 0.8 mut/kb (750 ng) or 1.5 mut/kb (500 ng), respectively. Black bars represent the experimentally
observed number of mutations after sequencing a small subset of clones. (C, D) Expected number and distribution of amino acid changes per clone
at a mutation rate of 0.8 mut/kb (750 ng, C) or 1.5 mut/kb (500 ng, D) (E) Expected and observed number and distribution of mutations after pooling
both libraries (500+750 ng) depicted as described in (A,B). (F) Expected number and distribution of amino acid changes per clone in our library with
an estimated mutation rate of 1.3 mut/kb. (G) Scatter blot showing the mutation rate for each nucleotide position of the coding region of PTGIR as
determined by next generation sequencing. The overall mutation rate was 1.48 mutations/kb. (H) Comparison of the observed codon changes in our
library (bars) with the expected codon changes (considering an unbiased mutation rate and one nucleotide substitution per codon, red symbol).
doi:10.1371/journal.pone.0097973.g001
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Therefore, we pooled our two epPCR reactions, resulting in a
library of .4000 hIP receptor constructs with a mutation rate of
approximately 1.3 mutations/kb (Figure 1E, F).
Analysis of mutagenesis libraries by next generation
sequencing provides valuable information about
coverage, mutation rate and mutational bias
Sanger sequencing is a rapid and cost-effective method to
determine the mutation rate of a subset of clones which can be
used to predict the expected mutation rate of the library. Due to
limitations in throughput, scalability and coverage range, sequenc-
ing efforts are typically focused on a subset of clones only.
However, sequencing of only a subset of clones does not provide
reliable information about the mutational coverage of the targeted
region or the expected mutational bias. NGS has made it possible
to process multiple sequencing reactions in parallel, enhancing
throughput and allowing for better coverage and resolution. To
analyze the quality of our mutagenesis library and to obtain more
reliable information about coverage and mutation rate, we
sequenced our complete mutagenesis library for the hIP receptor
using NGS. The pooled library was sequenced on an Illumina
HiSeq 2000 (Axeq Technologies); the 101 bp paired-end reads
were aligned to the wildtype-sequence of hIP receptor and the
mutations were assessed (Table 4). The average coverage for the
coding region of hIP receptor was ,21000 reads. The data
revealed a homogenous coverage of the complete coding region of
hIP receptor with only a few outliers (Figure 1G). The overall
mutation rate was 1.48 mutations/kb, very similar to our predicted
mutation rate of 1.3 mutations/kb. We used the NGS data to
assess the mutational bias in our library of .4000 hIP receptor
clones (Table 5). We found no bias for the mutation of purines and
pyrimidines, i.e. A’s and T’s were mutated at a similar rate as G’s
and C’s (ratio 0.76). Transition mutations were more abundant
than transversions (ratio 1.36). Mutations resulting in C’s or G’s
were ,4 times less likely than mutations resulting in T’s and A’s,
favoring substitution in certain amino acids over others. These
results are in accordance with previous reports and highlight the
known mutational bias resulting from polymerase mediated
mutagenesis [29,32]. Comparison of the expected codon changes
(considering an unbiased mutation rate and one nucleotide
substitution per codon) with the observed codon changes in our
NGS data showed a good overlap, indicating that the bias in
nucleotide substitution only partially translates into a bias in amino
acid substitutions (Figure 1H) [33]. Taken together, these data
demonstrate the utility of NGS for validating the quality of
mutagenesis libraries and for providing valuable information
about coverage, mutation rate and potential mutational bias.
Further optimization and the development of novel mutagenesis
techniques are needed to generate mutagenesis libraries with less
bias and increasing biological diversity.
Functional characterization of hIP receptor library
identified 32 mutants with reduced activity
In order to identify functional mutations of hIP receptor we
tested the .4000 mutants in our library for activity using hIP
receptor-mediated production of cAMP as a readout. The
GloSensor cAMP assay utilizes a genetically encoded biosensor
variant with cAMP binding domains fused to luciferase. Upon
binding to cAMP, conformational changes occur that promote
large increases in light output upon addition of a chemilumines-
cent substrate [34,35]. We transiently transfected HEK293T cells
stably expressing the GloSensor cAMP construct with our hIP
receptor constructs and stimulated cAMP production with the
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selective hIP receptor agonist (4-[(5,6-Diphenylpyrazin-2-yl)(iso-
propyl)amino]butoxy)acetic acid (MRE-269) [36]. Primary hits
were defined as mutants that resulted in ,25% of the response to
MRE-269 in cells transfected with the wild-type hIP receptor
(Figure 2A). To eliminate false-negative hits due to insufficient
transfection or deficiencies in trafficking of the receptor, we
validated cell surface expression of ,800 hIP receptor mutants in
a subsequent step, utilizing the extracellular, N-terminal HA-tag of
the protein. High content imaging of non-permeabilized cells
stained with a fluorescently-labeled anti HA-antibody identified 34
mutants which demonstrated a loss of hIP receptor function but
showed some cell surface expression of the receptor (for
representative images see Figure 2B). These mutants were selected
for analysis by sequencing, and cell surface expression and
functional characterization were confirmed in 3 independent
repeats of the assay (Figure 2C). Of these 34 mutants, 18 were
expressed at the cell surface and demonstrated full or partial loss of
receptor function.
Random mutagenesis of hIP receptor identified inactive
mutants
The observed distribution of mutations within the 18 clones
showed an enrichment in clones with .1 mutations as compared
to the distribution of the complete library (Figure 3A, Table 6),
reflecting the higher probability of accumulated mutations to
result in non-functional sequences [31]. A total of 38 non-
synonymous mutations were identified within the coding region of
hIP receptor, mapping to 36 distinct residues across the whole
length of the protein (Figure 3B, Table 6). As depicted in Table 6
and Figure 3A, most of the mutants contained more than one non-
synonymous mutation, making the interpretation challenging.
Further work is therefore required to deduce which mutations are
causative of loss of function. However, our hits included several
previously reported mutations affecting the signaling of hIP
receptor (Table 7). As shown in Figure 3B, our data identified
three regions of hIP receptor with an accumulation of inactive
mutations, indicating regions critical for hIP receptor function: 1)
Table 3. Estimated distribution of amino acid (AA) changes relative to the mutation rate (library size: 4000 plasmids).
mutation Estimated number of plasmids with indicated number of amino acid (AA) changes
rate 0 AA 1 AA 2 AA .2 AA
0.5 mut/kb 2494 1179 278 49
0.6 mut/kb 2269 1287 365 80
0.7 mut/kb 2064 1366 452 117
0.8 mut/kb 1878 1420 537 164
0.9 mut/kb 1708 1454 618 219
1.0 mut/kb 1554 1470 694 283
1.1 mut/kb 1414 1471 765 350
1.2 mut/kb 1286 1460 828 427
1.3 mut/kb 1170 1439 884 507
1.4 mut/kb 1065 1410 933 592
1.5 mut/kb 969 1374 974 682
1.6 mut/kb 881 1334 1009 777
1.7 mut/kb 802 1289 1036 873
1.8 mut/kb 729 1242 1057 971
1.9 mut/kb 663 1193 1071 1073
2.0 mut/kb 603 1142 1080 1173
2.1 mut/kb 549 1091 1083 1276
2.2 mut/kb 499 1040 1082 1379
2.3 mut/kb 454 989 1076 1481
2.4 mut/kb 413 939 1066 1582
2.5 mut/kb 376 890 1052 1683
doi:10.1371/journal.pone.0097973.t003
Table 4. NGS results: Number of reads for each base are shown relative to reference base.
Read_A Read_C Read_G Read_T
Ref_A 2649114 244 2231 1511
Ref_C 4832 9716863 903 8154
Ref_G 7020 1206 7653501 2987
Ref_T 2869 4218 478 4624499
doi:10.1371/journal.pone.0097973.t004
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the region around Tyr-75, 2) the region around Cys-165 and 3) the
region around Pro-289. Stitham et al. identified the highly
conserved residues Arg-279 and Tyr-75 as lying within the PGl2
binding pocket of the hIP receptor and to be critical for ligand
binding [14–16]. Cys-165 is described to form a non-conserved
disulfide-bridge in human hIP receptor and mutations at this
Table 5. Characteristics of the hIP receptor mutant library (4000 plasmids).
Transition (Ts) % Transversion (Tv) %
A-.G 55.97 A-.T 37.88
T-.C 55.75 T-.A 38.30
G-.A 60.02 A-.C 6.12
C-.T 58.07 T-.G 6.11
G-.C 10.72
Bias indicator C-.G 6.51
Ts/Tv 1.37 G-.T 26.63
AT-.GC/GC-.AT 0.75 C-.A 34.33
A-.N, T-.N 51.39%
G-.N, C-.N 48.61% Mutation rate 1.48 mut/kb
doi:10.1371/journal.pone.0097973.t005
Figure 2. Error-prone PCR mediated mutagenesis of hIP receptor identified 32 mutants with reduced activity. (A) Scatter blot showing
activity data of the hIP receptor library in the primary screen. Cells stably expressing the GloSensor cAMP plasmid were transfected with our hIP
receptor constructs and stimulated with 1 mM MRE-269. The luminescent signal was normalized to the signal obtained in hIP receptor wild-type
transfected cells. The experiment was performed in duplicates, shown on separate axis. Red box indicates clones with ,25% activity as compared to
wild-type hIP receptor. (B) Exemplary images of vector or hIP receptor expressing cells, stained with Alexa-647 anti HA-antibody. (C) Bar chart
showing the relative expression level (as assessed by staining with Alexa-647 anti-HA-antibody) and the relative activity (as assessed by GloSensor
cAMP assay) for 34 selected constructs. Asterisk indicates mutants classified as hits. Data were normalized to hIP receptor wild-type expressing cells
and represents the mean 6 SEM of three independent experiments.
doi:10.1371/journal.pone.0097973.g002
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position has been shown to affect receptor expression, dimeriza-
tion and activation [2,3]. Pro-289 maps to TMVII and is part of
the highly conserved DPXXF motif of the hIP receptor, a region
involved in receptor activation [14,15]. Our list of mutations also
included a mutation of Asn-78 to Ile (N78I), a known glycosylation
site of IP-receptor and previously implicated in receptor activation
and ligand binding [37], Met-99, previously identified to
contribute to ligand binding [16] and Ser-106, described to
contribute to the process of signal transduction and receptor
activation [17]. Notably, we identified the mutations shown in
Tables 6 and 7 and Fig. 3B in a single random mutagenesis
experiment. Thus, our findings corroborate the advantages of an
unbiased random mutagenesis approach over targeted, site-
directed mutagenesis of selected residues in multiple experiments.
Taken together, these data prove the usefulness of random
mutagenesis to gain insights in the structure-function requirements
of hIP receptor and to identify mutations that prevent activation of
the receptor.
Conclusions
The recent advantages in sequencing techniques have allowed
us to study genetic variants of genes at a genome-wide scale. A
growing list of studies and clinical trials has started to investigate
the role of SNPs in the origin and natural progression of diseases.
However, the great number of identified variants and the often low
prevalence have complicated the studies and only an unexpectedly
small number of novel examples linking genetic variations to
cardiovascular disease have been described [38]. Recent genomic
sequencing studies have identified numerous SNPs in the PTGIR
gene encoding the hIP receptor [14,39–41]. Comparison of these
mutations with the available data of previously biochemically
characterized mutants has revealed a correlation between genetic
variants in the hIP receptor resulting in deficits of hIP receptor
function with increased disease severity in patients with coronary
artery disease [10,11]. Thus, detailed biochemical analysis of
genetic variances in functional assays and insights into the
structure/function relationship of the protein of interest can
support the discovery of functional correlations of naturally
occurring genetic variances and disease. In addition, information
about the structural requirements underlying receptor function
and dysfunction can aid to guide rational drug design and the
development of novel therapies for cardiovascular disease.
Here we compared the applicability of chemical mutagenesis
and epPCR mediated mutagenesis to generate an unbiased library
of hIP receptor mutant plasmids, covering the complete coding
region of PTGIR. We found that while chemical mutagenesis is
especially useful to generate libraries with low frequencies of
Figure 3. Functional characterization of hIP receptor identified inactive mutants of hIP. (A) Bar chart depicting the number and
distribution of amino acid changes found in the 18 inactive mutants. Black bars represent the total number of amino acid changes; grey bars
represent non-synonymous mutations only. (B) Bar chart showing the number and position of all 38 identified non-synonymous mutations in hIP
receptor. Black boxes represent the a-helical, membrane-spanning domains of hIP receptor.
doi:10.1371/journal.pone.0097973.g003
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mutations it was not suitable for receptor mutation studies like the
hIP receptor, where higher mutation rates are needed to guarantee
sufficient coverage of the complete coding sequence [32,42]. We
describe a simple algorithm to simulate the optimal number and
distribution of mutated amino acid in mutagenesis libraries as a
function of the mutation rate. Using this simulation we determined
the optimal mutation rate needed to generate a library of .4000
mutants of the hIP receptor by epPCR. We analyzed the quality of
our library using NGS and present NGS as a rapid and non-
laborious approach to determine the exact mutation rate and the
mutational bias in the final library. The functional characteriza-
tion of our library of.4000 mutants of the hIP receptor generated
by epPCR identified 18 mutants of the hIP receptor with partial or
complete loss of receptor activity while maintaining cell surface
expression, translating into a hit rate less than 0.5%. Given the
,800 mutants with impaired receptor activity in our primary
screen (,18% hit rate – not controlled for membrane expression),
the difference in hit rate highlights the importance to determine
the optimal mutation rate needed to avoid the accumulation of
multiple mutations in one construct, thereby increasing the risk of
preventing proper folding and trafficking to the membrane. The
mutations identified in this mutagenesis screen included multiple
novel mutations as well as mutations mapping to residues
previously reported to affect the signaling of the hIP receptor
[9,11,14–17,37]. In these 18 constructs, we identified mutations
across the whole length of the protein, mapping to 36 distinct
residues of the hIP receptor. Due to the prevalence of multiple
mutations within each construct, further work is required to
characterize the novel mutations identified in this study. Notably,
all these mutants were identified in a single experiment,
highlighting the utility of unbiased mutagenesis approaches to
investigate the structure-function relationship of GPCRs and other
protein classes. Taken together, the results presented in this study
demonstrate that epPCR mediated mutagenesis is a valuable
method for unbiased screening of residues regulating hIP receptor
expression and function.
Table 6. Summary of identified non-synonymous mutations in hIP-receptor.
Clone ID mutations
1 A40S C259Y F295S
3 L81V C151Y C309R
4 C165R P359L
5 G103R S106Y A382V
6 N78I E343D C346R
7 D3E L253M A282T
8 P289L
9 V71M
10 M99T L224P C259R
12 N203I V371E
13 V11M G167D
19 V71M A128T V148I S168N R279L
21 P285L
22 Y75F
29 A50E P166S
30 Q163R
32 A152T N284K
Amino acid previously identified to be critical for hIP-function are in bold. Clone 33 contained a mutation in the HA-tag.
doi:10.1371/journal.pone.0097973.t006
Table 7. Overview of identified mutations in hIP-receptor previously reported in literature.
Mutation
identified previously reported Literature
R279L R279C [16]
P289L P289A [15]
Y75F Y75A [16]
M99T M99L [16]
S106Y S106A [17]
N78I N78Q [37]
C165R C165S [3]
doi:10.1371/journal.pone.0097973.t007
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